Skip to main content

Table 6 Test-restest reliability of the FH KAP questionnaire

From: Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia

No KAP Domain Item Kappa value Domain Kappa value Average Kappa value
Knowledge domain 0.796
3 Description of FH 0.879 0.818
4 Identification of lipid profile in FH 0.865
6 Prevalence of FH globally 0.759
7 Transmission of FH to first-degree relative 0.811
8 Rate of CAD risk in untreated FH 0.755
9 (a) Age for premature CAD (males) 0.920
9 (b) Age for premature CAD (females) 0.923
11 Genetic test for diagnosis of FH 0.650
22 Target LDL-c in FH 0.854
23 Important family history in FH 0.695
24 Exclusion of the diagnosis of FH 0.869
25 Management options in FH 0.835
Awareness domain
1 Familiarity with FH 0.819 0.810
2 Awareness of NICE clinical guideline 0.769
15 Awareness of lipid specialist 0.920
19 Awareness of other FH clinical guidelines 0.648
20 Awareness of FH diagnostic criteria 0.893
Practice domain
5 Assistance in detection of FH 0.877 0.760
10 Screening for FH in premature CAD 0.641
12 Family screening in FH patients 0.507
13 Most effective provider in FH detection 0.622
14 Age of FH screening among young person 0.685
16 Referral to lipid specialist 1.000
17 Pharmacotherapy used for hypercholesterolaemia 0.943
18 Combined pharmacotherapy used for severe hypercholesterolaemia 0.692
21 CAD risk stratification in FH 0.872
  1. FH, familial hypercholesterolaemia; CAD, coronary artery disease; LDL-c, low density lipoprotein cholesterol; NICE, National Institute for Health and Care Excellence;